• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受慢性免疫抑制治疗的女性的更年期——如何帮助这些患者。

Menopause in women with chronic immunosuppressive treatment - how to help those patients.

作者信息

Cyganek Anna, Pietrzak Bronisława, Wielgoś Mirosław, Grzechocińska Barbara

机构信息

1 Chair and Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Prz Menopauzalny. 2016 Mar;15(1):1-5. doi: 10.5114/pm.2016.58765. Epub 2016 Mar 29.

DOI:10.5114/pm.2016.58765
PMID:27095951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4828501/
Abstract

Women after organ transplantation with chronic immunosuppressive therapy or after bone marrow transplantation without such therapy are a growing group of patients. Although their problems in the peri- and postmenopausal period are the same as in healthy women, due to the primary disease and treatment applied they represent a huge challenge from the point of view of their hormonal treatment of menopause. Transplanted women have no particular contraindications for hormonal therapy use. General contraindications, however, such as arterial hypertension, thrombosis in medical history, diabetes, endometriosis, myomas, or active neoplastic disease, have a higher incidence in this group of patients than in healthy women, which significantly influences the possibility of using hormonal therapy. On the other hand, taking into consideration the predisposition for premature menopause in this group, in combination with chronic immunosuppression, it predisposes these patients for higher cardiovascular disease incidence and bone density loss, so hormonal therapy would be highly advisable. Therapy management in transplanted patients requires special care and close monitoring of the transplanted organ. Saving lives with organ transplantation is one of the greatest achievements of contemporary medicine. For long-term improvement of their quality of life, emphasis should be put on regular diagnostic examinations, early detection of abnormalities, and introduction of effective treatment.

摘要

接受慢性免疫抑制治疗的器官移植女性或未接受此类治疗的骨髓移植女性患者群体正在不断扩大。尽管她们在围绝经期和绝经后期的问题与健康女性相同,但由于原发性疾病和所采用的治疗方法,从更年期激素治疗的角度来看,她们面临着巨大挑战。移植女性使用激素疗法没有特殊禁忌证。然而,一般禁忌证,如动脉高血压、病史中有血栓形成、糖尿病、子宫内膜异位症、肌瘤或活动性肿瘤疾病,在这组患者中的发生率高于健康女性,这显著影响了使用激素疗法的可能性。另一方面,考虑到这组患者有过早绝经的倾向,再加上慢性免疫抑制,使这些患者患心血管疾病的发生率更高且骨密度降低,因此激素疗法非常可取。移植患者的治疗管理需要特别小心并密切监测移植器官。器官移植挽救生命是当代医学最伟大的成就之一。为了长期改善她们的生活质量,应强调定期进行诊断检查、早期发现异常并引入有效治疗。

相似文献

1
Menopause in women with chronic immunosuppressive treatment - how to help those patients.接受慢性免疫抑制治疗的女性的更年期——如何帮助这些患者。
Prz Menopauzalny. 2016 Mar;15(1):1-5. doi: 10.5114/pm.2016.58765. Epub 2016 Mar 29.
2
Endometriosis: seeking optimal management in women approaching menopause.子宫内膜异位症:绝经前女性的最佳管理方法探讨。
Climacteric. 2019 Aug;22(4):329-338. doi: 10.1080/13697137.2018.1549213. Epub 2019 Jan 10.
3
Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature.绝经后子宫内膜异位症病史男性的激素替代治疗:文献综述。
Medicina (Kaunas). 2019 Aug 14;55(8):477. doi: 10.3390/medicina55080477.
4
5
The management of menopause in women with a history of endometriosis: a systematic review.有子宫内膜异位症病史女性的绝经管理:一项系统综述
Hum Reprod Update. 2017 Jul 1;23(4):481-500. doi: 10.1093/humupd/dmx011.
6
Bisphosphonates for prevention of postmenopausal osteoporosis.双膦酸盐用于预防绝经后骨质疏松症。
Dan Med Bull. 2002 Feb;49(1):1-18.
7
Peculiarities of arterial hypertension in postmenopausal women with bone mineral density disorders and dyslipidemia.患有骨矿物质密度紊乱和血脂异常的绝经后女性动脉高血压的特点
Pol Merkur Lekarski. 2020 Feb 26;48(283):5-9.
8
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.美国国立卫生研究院关于更年期相关症状管理的科学现状会议声明。
NIH Consens State Sci Statements. 2005;22(1):1-38.
9
Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?脂质与心血管疾病:这些研究结果及治疗方法对男性和女性同样适用吗?
Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3. doi: 10.1016/s1049-3867(05)80278-6.
10
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识(共4部分,第1部分)
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.

引用本文的文献

1
Sex and Gender Differences in Face and Upper Extremity Allotransplantation: A Narrative Review of Implications and Impact.面部及上肢同种异体移植中的性别差异:影响与作用的叙述性综述
Cureus. 2025 Jan 24;17(1):e77938. doi: 10.7759/cureus.77938. eCollection 2025 Jan.
2
Differential analysis of quantitative proteome and acetyl-proteome profiling between premenopausal and postmenopausal ovarian tissues.绝经前和绝经后卵巢组织之间定量蛋白质组和乙酰化蛋白质组图谱的差异分析。
Clin Proteomics. 2018 Nov 16;15:36. doi: 10.1186/s12014-018-9214-0. eCollection 2018.
3
Research on Establishment of Abnormal Phlegmatic Syndrome with Premature Ovarian Failure Rat Model and Effects of Balgham Munziq Treatment.基于卵巢早衰大鼠模型建立异常痰湿证及白里香蒙孜克治疗作用的研究
Evid Based Complement Alternat Med. 2018 Mar 26;2018:3858209. doi: 10.1155/2018/3858209. eCollection 2018.
4
Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study.异黄酮、钙、维生素D和菊粉可改善绝经后女性的生活质量、性功能、身体成分和代谢参数:一项前瞻性、随机、安慰剂对照、平行组研究的结果。
Prz Menopauzalny. 2018 Mar;17(1):32-38. doi: 10.5114/pm.2018.73791. Epub 2018 Apr 11.

本文引用的文献

1
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.肝移植后实体器官癌症的发病率:与区域癌症发病率及危险因素的比较。
Liver Int. 2015 Jun;35(6):1748-55. doi: 10.1111/liv.12758. Epub 2015 Jan 21.
2
Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction.慢性移植物抗宿主病的妇科并发症:阴道梗阻。
Obstet Gynecol Sci. 2013 Jul;56(4):277-80. doi: 10.5468/ogs.2013.56.4.277. Epub 2013 Jul 15.
3
[Gynecological aspects of allogenic stem cell transplantation--incidence, risk factors and preventive strategies--description of two clinical cases and literature review].
Ginekol Pol. 2013 Sep;84(9):807-10. doi: 10.17772/gp/1644.
4
Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.移植肾五年后,持续性甲状旁腺功能亢进是骨折的一个主要危险因素。
Am J Transplant. 2013 Oct;13(10):2653-63. doi: 10.1111/ajt.12425. Epub 2013 Aug 26.
5
Quality of life and menopausal symptoms in women with liver transplants.肝移植女性的生活质量与更年期症状
Rev Bras Ginecol Obstet. 2013 Mar;35(3):103-10. doi: 10.1590/s0100-72032013000300003.
6
Influence of age and gender before and after liver transplantation.肝移植前后年龄和性别影响。
Liver Transpl. 2013 Feb;19(2):122-34. doi: 10.1002/lt.23574.
7
Is liver transplantation associated with decreased bone mass in climacteric women?
Rev Bras Ginecol Obstet. 2012 Jul;34(7):335-42. doi: 10.1590/s0100-72032012000700008.
8
Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.左炔诺孕酮宫内缓释系统在肾移植受者中的应用:回顾性病例分析。
Contraception. 2012 Sep;86(3):288-9. doi: 10.1016/j.contraception.2011.12.008. Epub 2012 Feb 2.
9
Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.肾移植术后有症状的绝经后女性的两种激素替代治疗途径。
Neuro Endocrinol Lett. 2006 Jun;27(3):387-91.
10
Safety and efficacy of hormonal therapy in menopausal kidney-allograft recipients.
Transplant Proc. 2006 Jan-Feb;38(1):184-7. doi: 10.1016/j.transproceed.2005.12.001.